Autopsy report · NCT02219048
An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma
Cause of deathFunding or business
“The termination was due to business reasons. No safety or efficacy concerns contributed to the termination of the study”
Life of this trial
- Registered 3 months before it started.
- Ran for about 6 months before it stopped.
- 51 participants enrolled.
- Results were posted on the registry 4 years 1 month after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Pfizer
- Sponsor type
- Industry
- Conditions
- Asthma
- Interventions
- Placebo; PF-03715455
- Participants
- 51
- Sites
- 28
- Countries
- United States
Trials that died the same way
- A Study of TCD601 (Siplizumab) in New Onset Type 1 Diabetes Patients
“The study has been early terminated due to business reasons. This decision is not related to any safety, efficacy, or regulatory concerns.” - Study of KHK 4323 in Healthy Volunteers and Subjects With Atopic Dermatitis
“The study terminated for safety reasons.” - Safety and Tolerability of PNT001 in Patients With Acute Traumatic Brain Injury (TBI)
“The study was terminated due to administrative, non-safety related reasons.” - Surgical Treatment of Chronic Neuropathic Pain
“The study was terminated due to lower than expected enrollment. The decision to terminate the study was not based on any safety or efficacy concerns.” - Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole
“This study was terminated for reasons not related to efficacy or safety”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.